Effectiveness and Safety of Retreatment with <sup>177</sup>Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States.
作者:
主题词
人类(Humans);男(雄)性(Male);神经内分泌瘤(Neuroendocrine Tumors);回顾性研究(Retrospective Studies);女(雌)性(Female);中年人(Middle Aged);奥曲肽(Octreotide);有机金属化合物(Organometallic Compounds);美国(United States);老年人(Aged);疾病恶化(Disease Progression);治疗结果(Treatment Outcome);成年人(Adult);再治疗(Retreatment);安全(Safety);老年人, 80以上(Aged, 80 and over)
DOI
10.2967/jnumed.123.265703
PMID
38514088
发布时间
2024-05-01
- 浏览0

Journal of nuclear medicine
746-752页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文